Clinical Trial: GS-US-587-6156

Trial Status: Open
Disease Type: Colorectal
Trial ID GS-US-587-6156
Sponsor ID Gilead Sciences, Inc

A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (CRC)

Principal Investigator
Keeran R. Sampat, MD
3 Locations

Locations

Arlington Office

Fairfax Office

Gainesville Office

Learn More About This Trial
Other Relevant Trials
Trial ID C-800-25
Sponsor ID Agenus

“A RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY OF BOTENSILIMAB (AGEN1181) AS MONOTHERAPY AND IN COMBINATION WITH BALSTILIMAB (AGEN2034) FOR THE TREATMENT OF ADVANCED, REFRACTORY MICROSATELLITE STABLE COLORECTAL CANCER WITHOUT LIVER METASTASES”

Principal Investigator
Chao Yin, MD
2 Locations
Trial ID 21386
Sponsor ID BNT122-01

“A multi-site, open-label, Phase II, randomized, controlled trial to compare the efficacy of RO7198457 versus watchful waiting in resected, Stage II (high risk) and Stage III colorectal cancer patients who are ctDNA positive following resection (BNT122-01)”

1 Location